IL187168A0
(en )
2008-02-09
Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL1765391T3
(en )
2013-08-30
Bacterial compositions for the treatment of cancer
IL233634A0
(en )
2014-08-31
Methods, compositions, and kits for the treatment of medical conditions
PL381247A1
(en )
2007-05-14
Heterocyclical condensed derivative, the medical composition containing it as well as its treatment application
IL191832A0
(en )
2008-12-29
Pyridiazinone derivatives for the treatment of tumours
AP2006003525A0
(en )
2006-02-28
Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
WO2007146965A3
(en )
2008-12-04
Compounds for the treatment of periodontal disease
PL2803366T3
(en )
2018-12-31
Compositions for treating or preventing oxalate-related disease
ZA200706113B
(en )
2008-09-25
Method for the treatment of copper-bearing materials
IL186748A0
(en )
2008-02-09
4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility
PT1945243E
(en )
2015-10-12
Use of calcitonin for the treatment of ra
GB0400802D0
(en )
2004-02-18
Compounds for the treatment of disease
IL187792A0
(en )
2008-11-03
4-anilino-3-quinolinecarbonitriles for the treatment of cancer
PL1959957T3
(en )
2012-12-31
Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
GB0511769D0
(en )
2005-07-20
Treatment
GB0517387D0
(en )
2005-10-05
Combinations for the treatment of cancer
ZA200805522B
(en )
2009-04-29
Dioxoiane dérivates for the treatment of cancer
GB0426141D0
(en )
2004-12-29
Treatment
AP2005003270A0
(en )
2005-03-31
Composition for the treatment of humans.
GB0505203D0
(en )
2005-04-20
Skin composition treatment
ZA200606780B
(en )
2008-08-27
Compounds for the treatment of diseases
TJ20050863A
(en )
2007-06-05
The way of narcotism treatment
GB0413845D0
(en )
2004-07-21
The treatment of emesis
GB0423927D0
(en )
2004-12-01
The treatment of IBD
GB0517386D0
(en )
2005-10-05
Combinations for the treatment of cancer